Modern Mobility Aids, Inc. Announces Name Change

Modern Mobility Aids, Inc. (“the Company”) (OTC Pink: DRM) announced today that the Board of Directors and shareholders approved the Company’s name change to Galileo Life Sciences, Inc.

“We are very pleased to adopt the name Galileo Life Sciences. We believe it better reflects our objective to nurture innovative solutions that enhance the quality of life for all through investments and operations in various strategic growth areas – the production and distribution of high grade medical marijuana in North America and advanced health and life science products and services,” stated President, Preston Shea. “It is also aligned with our commitment to leading edge research and development in support of these rapidly growing alternative trends and technologies.”

The name change is effective immediately. The Company expects its new ticker symbol to be available within days. “Further significant announcements are planned for the near future,” concluded Shea.

About Galileo Life Sciences, Inc.

Galileo Life Sciences, Inc. is a company strategically focused on the production and distribution of premium medical marijuana in North America and advanced health and life science and services that nurture innovative solutions to enhance the quality of life for all. The Company also has a commitment to leading edge research and development in support of these rapidly growing alternative health and life sciences trends, technologies and services. Galileo Life Sciences is listed on the New York OTC Pink Market and currently trades under the ticker symbol MDRM.

For more information please contact:

Galileo Life Sciences, Inc.
Preston J. Shea, President, Treasurer and Secretary
Email: p.shea@galileolifesciences.com
Tel: 416-642-2593

Safe Harbor

This news release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the “Act”). In particular, when used in the preceding discussion, the words “believe”, “expects”, “reflects”, “aligned”, “anticipates”, “planned”, and similar conditional expressions are intended to identify forward-looking statements within the meaning of the Act and are subject to the safe harbor created by the Act. Such statements are subject to certain risks and uncertainties and actual results could differ materially from those expressed in any of the forward-looking statements. There are no guarantees or assurances that any initiatives will result in what the Company had originally intended. Any investment made into Galileo Life Sciences, Inc., would be classified as speculative and risky. Such risks and uncertainties include, but are not limited to, market conditions, general acceptance of the Company’s products and technologies, competitive factors, the ability to successfully complete additional or adequate financing, government approvals or changes to proposed laws and other risks and uncertainties further stated in the Company’s financial reports and filings.

Posted in: Press

Comments are closed.